Prognostic value of the expression of ABH isoantigens in tumors of the bladder urothelium
Anton Aparicio, L.M.; Martín Algarra, S.; Sánchez de la Muela, P.; Berián Polo, J.M.
Revista de Medicina de la Universidad de Navarra 33(2): 111-112
1989
ISSN/ISBN: 0556-6177 PMID: 2489254 Document Number: 337817
The usefulness of studying ABH isoantigens associated to bladder cancer cells with the specific red blood cells adherence assay, and immunohistochemistry methods in urinary bladder carcinoma biopsies, as well as its application as early predictors of tumor invasiveness and relapse, is reviewed.
Document emailed within 1 workday
Related Documents
Rammeh-Rommani, S.; Zermani, R.; Sfaxi, M.; Chabchoub, A.; Zouari, B.éc.; Ayed, M.; Ben Jilani-Baltagi, S. 2007: Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder La Tunisie Medicale 85(6): 509-512Baranyay, F.; Knels, R.; Somogyi, L. 1992: The distribution of ABO(H) isoantigens in urinary bladder tumours Acta Medica Hungarica 49(1-2): 129-136
Tosner, J. 1981: The value of estimation of ABH isoantigens in gynecological tumors Ceskoslovenska Gynekologie 46(9): 699-703
Páez Borda, A.; Martín Osés, E.; de la Cal López, M.; Llorente Abarca, C.; Berenguer Sánchez, A. 1997: Analysis of prognostic factors in superficial bladder tumors Archivos Espanoles de Urologia 50(2): 121-126
Jost, S.P.; Gosling, J.A.; Dixon, J.S. 1989: The morphology of normal human bladder urothelium Journal of Anatomy 167: 103-115
Kolozsy, Z.; Mohácsi, L.; Dauda, G.; Samodai, L.; Endresz, K.F.; Tóth, A. 1989: Significance of seemingly intact urothelium in patients with bladder cancer Orvosi Hetilap 130(36): 1925-1926; 1929-1931
Cancrini, A.; Marcellino, L.R.; Franceschini, R.; Micieli, G. 1975: Diagnostic and prognostic evaluation of epithelial tumors of the urinary bladder in relation to their surgical treatment Annali Italiani di Chirurgia 47(5): 475-495
Borella, T.; Loro, M.; Dato, I.; Merlo, F.; Giudici, M. 1986: Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder Minerva Medica 77(34-35): 1527-1532
Ben Rejeb, A.; Mahjoub, A.; Berraies, N.; Tissaoui, K. 2000: Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors Annales d'Urologie 34(4): 240-248
Casetta, G.; Gontero, P.; Russo, R.; Pacchioni, D.; Tizzani, A. 1997: p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder European Urology 32(2): 229-236
Shah, K.V.; Pond, H.S. 1972: Attempts to produce urinary bladder cancer in dogs by inoculation of simian virus 40 into the urothelium Investigative Urology 10(2): 141-143
Ben-Aïssa, H.; Paulie, S.; Gustafsson, B.; Håkansson, L.; Lagerkvist, M.; Gustafson, H.; Ahlstrand, C.; Perlmann, P. 1988: Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium Anticancer Research 8(3): 443-449
Vestergaard, E.M.; Wolf, H.; Orntoft, T.F. 1998: Increased concentrations of genotype-interpreted Ca 19-9 in urine of bladder cancer patients mark diffuse atypia of the urothelium Clinical Chemistry 44(2): 197-204
Maier, U.; Kuber, W. 1983: Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors Fortschritte der Medizin 101(12): 535-540
Martínez-Consuegra, N.; Baquera-Heredia, J.; de León-Bojorge, B.; Padilla-Rodríguez, A.; Hidalgo, C.O. 2006: Expression of p53 and BCI-2 as prognostic markers and for anatomical location in gastrointestinal stromal tumors (GIST). Clinico-pathological and immunohistochemistry study of 19 cases Revista de Gastroenterologia de Mexico 71(3): 269-278
Gregersen, B.; Mommsen, S.; Svanholm, H. 1999: Bladder tumor antigen test versus urinary cytology in patients with bladder tumors Ugeskrift for Laeger 161(14): 2071-2073
Rossi, D.; de Fromont, M.; Serment, G.; Rampal, M. 1992: Flow cytometry in bladder lavage fluid for the diagnosis and surveillance of bladder tumors. Preliminary results Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 2(4): 604-615
Cariou, G.; Maaraoui, N.; Cortesse, A. 1997: Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder? Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(1): 51-55
Gibbons, R.P. 1993: Bladder sparing in infiltrating tumors of the bladder: a reasonably sound option? Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 3(1): 17-18
Escudero Barrilero, A.; Platas, A.; Fernández, A.; Fernández, E.; Rodríguez Luna, J.M.; Ruiz, C.; Maganto, E.; Romero, J. 1989: Infiltrating transitional carcinoma of the bladder. Is the P/T ratio a reliable index to evaluate the effectiveness of preoperative radiotherapy on tumors of the bladder? Archivos Espanoles de Urologia 42(3): 229-235